{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:55:12Z","timestamp":1780052112548,"version":"3.53.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jdiacomp.2019.107512","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T12:24:24Z","timestamp":1576499064000},"page":"107512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prospective evaluation of non-alcoholic fatty liver disease by elastographic methods of liver steatosis and fibrosis; controlled attenuation parameter and liver stiffness measurements"],"prefix":"10.1016","volume":"34","author":[{"given":"I.","family":"Mikolasevic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Lukenda Zanko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Jakopcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Domislovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mijic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Stevanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Delija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bokun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Dinjar Kujundzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ostojic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Filipec Kanizaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Grgurevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Krznaric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Stimac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Targher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2019.107512_bb0005","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3748\/wjg.v24.i14.1491","article-title":"Nonalcoholic fatty liver disease and liver transplantation - where do we stand?","volume":"24","author":"Mikolasevic","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cld.2015.10.002","article-title":"The metabolic syndrome and its influence on nonalcoholic steatohepatitis","volume":"20","author":"Kanwar","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0015","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace","volume":"56","author":"Baffy","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0020","doi-asserted-by":"crossref","first-page":"9488","DOI":"10.3748\/wjg.v22.i43.9488","article-title":"Nonalcoholic fatty liver disease - a multisystem disease?","volume":"22","author":"Mikolasevic","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2015.07.019","article-title":"Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease","volume":"14","author":"Mittal","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0030","doi-asserted-by":"crossref","unstructured":"Yasui K, Hashimoto E, Komorizono Y, Koike K, Arii S, Imai Y, et al; Japan NASH Study Group, Ministry of Health, Labour, and Welfare of Japan. Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Clin Gastroenterol Hepatol 2011;9:428\u2013433; quiz e50.","DOI":"10.1016\/j.cgh.2011.01.023"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep4.1124","article-title":"Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: a long-term follow-up study","volume":"2","author":"Hagstr\u00f6m","year":"2017","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14706-0","article-title":"Predictors of liver fat and stiffness in non-alcoholic fatty liver disease (NAFLD) - an 11-year prospective study","volume":"7","author":"Lallukka","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0045","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.3748\/wjg.v22.i32.7236","article-title":"Transient elastography (FibroScan(\u00ae)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - where do we stand?","volume":"22","author":"Mikolasevic","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0050","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/hep.29489","article-title":"Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease","volume":"67","author":"Vuppalanchi","year":"2018","journal-title":"Hepatology."},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0055","unstructured":"Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, et al. Accuracy of fibroscan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with non-alcoholic fatty liver disease. Gastroenterology. 2019 Jan 25. pii: S0016\u20135085(19)30105\u20132."},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0060","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jdiacomp.2016.05.014","article-title":"Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndrome","volume":"30","author":"Mikolasevic","year":"2016","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0065","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes","volume":"36","author":"Sasso","year":"2010","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0070","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ultrasmedbio.2015.08.008","article-title":"Liver steatosis assessed by controlled attenuation parameter (CAP) measured with the XL probe of the Fibroscan: a pilot study assessing diagnostic accuracy","volume":"42","author":"Sasso","year":"2016","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0075","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000350158","article-title":"Chronic kidney disease and nonalcoholic fatty liver disease proven by transient elastography","volume":"37","author":"Mikolasevic","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0080","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nrgastro.2013.175","article-title":"Noninvasive evaluation of NAFLD","volume":"10","author":"Castera","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clinre.2011.08.001","article-title":"The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan","volume":"36","author":"Sasso","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/gastro\/got007","article-title":"Update of liver fibrosis and steatosis with transient elastography (Fibroscan\u00ae)","volume":"1","author":"Wong","year":"2013","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0095","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/apt.12569","article-title":"Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease\u2013the role of transient elastography and plasma cytokeratin-18 fragments","volume":"39","author":"Kwok","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0100","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstr\u00f6m","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0105","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.dld.2011.12.005","article-title":"Screening for liver fibrosis by using FibroScan(\u00ae) and FibroTest in patients with diabetes","volume":"44","author":"de L\u00e9dinghen","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137239","article-title":"Transient elastography-based liver profiles in a hospital-based pediatric population in Japan","volume":"10","author":"Cho","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0115","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/HJH.0b013e32833c211b","article-title":"The association between fatty liver disease and blood pressure in a population-based prospective longitudinal study","volume":"28","author":"Lau","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0120","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1023\/A:1005661516165","article-title":"Fatty infiltration of liver in hyperlipidemic patients","volume":"45","author":"Assy","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000282080","article-title":"Epidemiology of non-alcoholic fatty liver disease","volume":"28","author":"Bellentani","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/liv.13299","article-title":"The epidemiology of non-alcoholic fatty liver disease","volume":"37","author":"Bellentani","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0135","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/gutjnl-2015-309265","article-title":"Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study","volume":"65","author":"Kwok","year":"2016","journal-title":"Gut."},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0140","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","author":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO)","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0145","doi-asserted-by":"crossref","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol 2015;62(1 Suppl.), S47\u2013S6.","DOI":"10.1016\/j.jhep.2014.12.012"},{"key":"10.1016\/j.jdiacomp.2019.107512_bb0150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.metabol.2017.11.003","article-title":"Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis","volume":"79","author":"Mantovani","year":"2018","journal-title":"Metabolism."}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872719306348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872719306348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:09:14Z","timestamp":1761005354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872719306348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1056872719306348"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2019.107512","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective evaluation of non-alcoholic fatty liver disease by elastographic methods of liver steatosis and fibrosis; controlled attenuation parameter and liver stiffness measurements","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2019.107512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107512"}}